Clinical Trials Browser

Phase NA × Neoplasm, Residual × Plasma cell × Clear all

NCT06697483 2024-11-25

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Phase NA Recruiting

Multiple Myeloma, Neoplasm, Residual

NCT05697913 2024-03-06

Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation

Phase NA Active not recruiting

Multiple Myeloma, Neoplasm, Residual